EP0536360A4 - Topical treatment of acne - Google Patents

Topical treatment of acne

Info

Publication number
EP0536360A4
EP0536360A4 EP19920908796 EP92908796A EP0536360A4 EP 0536360 A4 EP0536360 A4 EP 0536360A4 EP 19920908796 EP19920908796 EP 19920908796 EP 92908796 A EP92908796 A EP 92908796A EP 0536360 A4 EP0536360 A4 EP 0536360A4
Authority
EP
European Patent Office
Prior art keywords
acne
topical treatment
topical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920908796
Other languages
English (en)
Other versions
EP0536360A1 (de
Inventor
Howard N. Robinson
Neil F. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOWSEND MARVIN S
Original Assignee
TOWSEND MARVIN S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOWSEND MARVIN S filed Critical TOWSEND MARVIN S
Publication of EP0536360A1 publication Critical patent/EP0536360A1/de
Publication of EP0536360A4 publication Critical patent/EP0536360A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
EP19920908796 1991-03-05 1992-03-03 Topical treatment of acne Withdrawn EP0536360A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66479591A 1991-03-05 1991-03-05
US664795 1991-03-05

Publications (2)

Publication Number Publication Date
EP0536360A1 EP0536360A1 (de) 1993-04-14
EP0536360A4 true EP0536360A4 (en) 1993-08-04

Family

ID=24667469

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920908796 Withdrawn EP0536360A4 (en) 1991-03-05 1992-03-03 Topical treatment of acne

Country Status (4)

Country Link
EP (1) EP0536360A4 (de)
AU (1) AU656097B2 (de)
CA (1) CA2086259A1 (de)
WO (1) WO1992015299A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627195A (en) * 1995-04-11 1997-05-06 Massachusetts Eye And Ear Infirmary Treatment for ocular inflammation
MXPA05007813A (es) * 2003-03-10 2005-10-18 Xantech Pharmaceuticals Inc Composicion con mejor desempeno antimicrobiano para higienizar superficies.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287223A1 (fr) * 1974-10-10 1976-05-07 Beecham Group Ltd Composition pharmaceutique
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
EP0008525A2 (de) * 1978-08-25 1980-03-05 Beecham Group Plc Pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung
EP0296740A2 (de) * 1987-06-11 1988-12-28 Skandigen Ab Derivate von Hyaluronsäure und ihre Herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287223A1 (fr) * 1974-10-10 1976-05-07 Beecham Group Ltd Composition pharmaceutique
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
EP0008525A2 (de) * 1978-08-25 1980-03-05 Beecham Group Plc Pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung
EP0296740A2 (de) * 1987-06-11 1988-12-28 Skandigen Ab Derivate von Hyaluronsäure und ihre Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9215299A1 *

Also Published As

Publication number Publication date
EP0536360A1 (de) 1993-04-14
CA2086259A1 (en) 1992-09-06
AU656097B2 (en) 1995-01-19
WO1992015299A1 (en) 1992-09-17
AU1580092A (en) 1992-10-06

Similar Documents

Publication Publication Date Title
ZA945545B (en) Psoriasis treatment
GB9215633D0 (en) Novel treatment
PH25291A (en) Acne treatment
EP0559791A4 (en) Treatment of topical infections
AU3236093A (en) The use of ob-101 to treat inflammation
AU3235693A (en) The use of ob-104 to treat inflammation
GB9203039D0 (en) Treatment
GB9211148D0 (en) Novel treatment
GB2271579B (en) Treatment of wood
GB9222260D0 (en) Skin treatment
GB9201920D0 (en) Novel treatment i
GB8808247D0 (en) Treatment of prophylaxis of acne dandruff/related conditions
EP0536360A4 (en) Topical treatment of acne
GB9218711D0 (en) Skin cancer treatment
GB9100970D0 (en) Acne treatment composition
NZ255753A (en) Use of substituted azaspiranes for psoriasis treatment
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9218773D0 (en) Skin treatment
GB9103098D0 (en) Dermatological treatment
ZA891541B (en) Acne treatment
AU663868B2 (en) Treatment for acne
GB9308572D0 (en) Topical lotion for the treatment of alopecia
IE890675L (en) Acne treatment
GB9117210D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19930316

A4 Supplementary search report drawn up and despatched

Effective date: 19930614

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE ES FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 19970721

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/43 A, 7A 61K 31/545 B, 7A 61P 17/10 B

RTI1 Title (correction)

Free format text: PHARMACEUTICAL COMPOSITION FOR USE FOR THE TOPICAL TREATMENT OF ACNE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/43 A, 7A 61K 31/545 B, 7A 61P 17/10 B

RTI1 Title (correction)

Free format text: PHARMACEUTICAL COMPOSITION FOR USE FOR THE TOPICAL TREATMENT OF ACNE

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030114